4/A
Changes in Ownership
RECURSION PHARMACEUTICALS, INC. Filed Acc 0001601830-24-000102
Chief Executive Officer acquired 100,000 shares (conversion)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Gibson Christopher · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-06-05 | Conversion : show line 1 in the form 10b5-1 | +100,000 | 908,738 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-06-05 | Conversion : show line 2 in the form 10b5-1 Class B Common Stock | −100,000 | 6,326,700 | D |
Loading xslF345X05/wk-form4a_1720824741.xml…